This page shows the latest bioelectronic medicines news and features for those working in and with pharma, biotech and healthcare.
Will develop electronic implants to treat chronic diseases, including diabetes. GlaxoSmithKline has joined forces with Google's Verily Life Sciences to establish a new company dedicated to the development of bioelectronic ... Bioelectronic medicine is
GlaxoSmithKline (GSK) is setting up a $5m fund for external researchers working in the area of bioelectronic medicines, boosting its investment in the emerging technology. ... GSK was the first big pharma company to make a significant investment in
year and following that up with funding to support up to 20 research projects in the field and a $50m venture capital fund to support companies with bioelectronic medicines and technologies. ... companies are developing electronic devices that could add
GSK said that SetPoint's investigational device had “important hallmarks of future bioelectronic medicines”. ... These medicines are designed to read patterns of electronic signals in nerves, which can be irregular or altered in patients with certain
More from news
Approximately 1 fully matching, plus 3 partially matching documents found.
There was the August announcement that Google's Verily company was investing in the development of bioelectronic medicines with GSK via the newly formed Galvani Bioelectronics.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
No results were found
KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...